Third Harmonic Bio, Inc. (THRD)
USD 10.82
(-4.67%)
USD 10.82
(-4.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | - | - | - | - |
| Cost of Revenue | 35 Thousand | 38 Thousand | - | - |
| Gross Profit | -35 Thousand | -38 Thousand | - | - |
| Operating Expenses | 43.95 Million | 37.7 Million | 19 Million | 11.12 Million |
| Selling, General and Administrative Expenses | 19.99 Million | 13.3 Million | 3.25 Million | 1.16 Million |
| Research and Development Expenses | 23.96 Million | 24.4 Million | 15.74 Million | 9.95 Million |
| Other Expenses | - | 2.55 Million | -10.6 Million | -1.68 Million |
| Cost and Expenses | 43.95 Million | 37.7 Million | 19 Million | 11.12 Million |
| Operating Income | -43.95 Million | -37.7 Million | -19 Million | -11.11 Million |
| Interest Expense | - | 2.55 Million | - | - |
| Income Tax Expense | - | 2.55 Million | -19 Thousand | -1000.00 |
| Earnings before Tax | -30.82 Million | -35.15 Million | -29.6 Million | -12.8 Million |
| Net Income | -30.82 Million | -37.7 Million | -29.6 Million | -12.8 Million |
| Earnings Per Share Basic | -0.78 | -0.96 | -0.77 | -0.33 |
| Earnings Per Share Diluted | -0.78 | -0.96 | -0.77 | -0.33 |
| Weighted Average Shares Outstanding | 39.64 Million | 39.37 Million | 38.69 Million | 38.69 Million |
| Weighted Average Shares Outstanding (Diluted) | 39.64 Million | 39.37 Million | 38.69 Million | 38.69 Million |
| Gross Margin | - | - | - | - |
| EBIT Margin | - | - | - | - |
| Profit Margin | - | - | - | - |
| EBITDA | -30.78 Million | -35.11 Million | -10.6 Million | -1.68 Million |
| Earnings Before Tax Margin | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 836 Thousand | - | - |
| Cost of Revenue | 12 Thousand | 12 Thousand | 35 Thousand | 13 Thousand | 178 Thousand | 168 Thousand |
| Gross Profit | -12 Thousand | -12 Thousand | -35 Thousand | 823 Thousand | -178 Thousand | -168 Thousand |
| Operating Expenses | 14.05 Million | 11.27 Million | 43.91 Million | 10.39 Million | 10.84 Million | 10.71 Million |
| Selling, General and Administrative Expenses | 5.66 Million | 5.05 Million | - | 4.47 Million | 4.87 Million | 5.37 Million |
| Research and Development Expenses | 8.39 Million | 6.22 Million | - | 5.91 Million | 5.96 Million | 5.34 Million |
| Other Expenses | -1000.00 | 1000.00 | - | -6000.00 | 34 Thousand | -4000.00 |
| Cost and Expenses | 14.07 Million | 11.29 Million | 43.95 Million | 10.4 Million | 10.84 Million | 10.71 Million |
| Operating Income | -14.07 Million | -11.29 Million | -43.95 Million | -10.4 Million | 10.84 Million | -10.71 Million |
| Interest Expense | - | - | - | -2.9 Million | - | - |
| Income Tax Expense | - | -31.27 Thousand | - | 267 Thousand | -12 Thousand | -3.15 Million |
| Earnings before Tax | -10.7 Million | -7.85 Million | -30.82 Million | -6.83 Million | 7.34 Million | -7.56 Million |
| Net Income | -10.7 Million | -7.85 Million | -30.82 Million | -6.83 Million | 7.34 Million | -7.56 Million |
| Earnings Per Share Basic | -0.26 | -0.20 | - | -0.17 | 0.19 | -0.19 |
| Earnings Per Share Diluted | -0.26 | -0.20 | - | -0.17 | 0.19 | -0.19 |
| Weighted Average Shares Outstanding | 40.55 Million | 40.21 Million | 39.64 Million | 39.92 Million | 39.68 Million | 39.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 40.55 Million | 40.21 Million | 39.64 Million | 39.92 Million | 39.68 Million | 39.57 Million |
| Gross Margin | - | - | - | 0.98 | - | - |
| EBIT Margin | - | - | - | -12.43 | - | - |
| Profit Margin | - | - | - | -8.18 | - | - |
| EBITDA | -14.05 Million | -11.27 Million | - | -10.39 Million | 10.84 Million | -10.7 Million |
| Earnings Before Tax Margin | - | - | - | -12.45 | - | - |
600261
CLIME-B
BRE
WMLLF
000590
MSBHF